Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.71 -4.25 (-0.84%)
At close: Oct 1, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Return on Equity [ROE] (2011 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) posted Return on Equity [ROE] of -59.79% for Q2 2026, down 19.70 percentage points from -40.08% a year earlier and down 6.71 percentage points from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Madrigal Pharmaceuticals' Return on Equity [ROE] came in at -42.01%, up 38.34 percentage points from FY2024.

  • Annual Return on Equity [ROE] has increased for three consecutive years, with a five-year change of +19.63 percentage points (FY2020 to FY2025).
  • In prior years, Madrigal Pharmaceuticals' Return on Equity [ROE] was -80.35% in FY2024 (+43.63 pp), -123.98% in FY2023 (+26.14 pp), -150.12% in FY2022 (-39.07 pp) and -111.04% in FY2021 (-49.40 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2024.
  • On a year-over-year basis, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +81.89 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2024, with a gain of 488.94 percentage points; the weakest was Q3 2022, with a drop of 488.06 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -53.07% (Q1 2026), -46.41% (Q4 2025) and -43.28% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Madrigal Pharmaceuticals 14.69 Bn 10.94 Bn - -59.79%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.79%
Mar 31, 2026 -53.07%
Dec 31, 2025 -46.41%
Sep 30, 2025 -43.28%
Jun 30, 2025 -40.08%
Mar 31, 2025 -53.46%
Dec 31, 2024 -60.84%
Sep 30, 2024 -63.47%
Jun 30, 2024 -59.78%
Mar 31, 2024 -70.74%
Dec 31, 2023 -174.76%
Sep 30, 2023 -552.41%
Jun 30, 2023 -260.05%
Mar 31, 2023 -181.13%
Dec 31, 2022 -283.91%
Sep 30, 2022 -581.70%
Jun 30, 2022 -223.22%
Mar 31, 2022 -144.40%
Dec 31, 2021 -112.36%
Sep 30, 2021 -93.64%
API Access

Madrigal Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MDGL&period=max&api_key=YOUR_API_KEY